CA3012660C - Compositions d'agents alpha-adrenergique pour le traitement du ptosis - Google Patents

Compositions d'agents alpha-adrenergique pour le traitement du ptosis

Info

Publication number
CA3012660C
CA3012660C CA3012660A CA3012660A CA3012660C CA 3012660 C CA3012660 C CA 3012660C CA 3012660 A CA3012660 A CA 3012660A CA 3012660 A CA3012660 A CA 3012660A CA 3012660 C CA3012660 C CA 3012660C
Authority
CA
Canada
Prior art keywords
composition
alpha
adrenergic agent
adrenergic
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3012660A
Other languages
English (en)
Other versions
CA3012660A1 (fr
Inventor
Frank Litvack
Houman Hemmati
Original Assignee
Levation Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Levation Pharma Ltd filed Critical Levation Pharma Ltd
Priority claimed from PCT/US2017/015181 external-priority patent/WO2017132410A1/fr
Publication of CA3012660A1 publication Critical patent/CA3012660A1/fr
Application granted granted Critical
Publication of CA3012660C publication Critical patent/CA3012660C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

L'invention concerne des compositions cosmétiques et thérapeutiques d'agents alpha-adrénergiques. Les compositions de l'invention peuvent être utilisées pour l'administration topique, transdermique ou parentérale sur l'œil ou une paupière. Les compositions de l'invention peuvent être utilisées en cosmétique pour améliorer l'aspect de l'œil ou thérapeutiquement pour traiter le ptosis.
CA3012660A 2016-01-26 2017-01-26 Compositions d'agents alpha-adrenergique pour le traitement du ptosis Active CA3012660C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662287391P 2016-01-26 2016-01-26
US62/287,391 2016-01-26
PCT/US2017/015181 WO2017132410A1 (fr) 2016-01-26 2017-01-26 Compositions et utilisations d'agents alpha-adrénergiques

Publications (2)

Publication Number Publication Date
CA3012660A1 CA3012660A1 (fr) 2017-08-03
CA3012660C true CA3012660C (fr) 2025-12-09

Family

ID=

Similar Documents

Publication Publication Date Title
AU2024200121B2 (en) Compositions and uses of alpha-adrenergic agents
DK2767292T3 (en) RENEWABLE local anesthetic COMPOSITION CONTAINING SAIB
US10206876B2 (en) Depot formulations of a local anesthetic and methods for preparation thereof
JP2011513501A (ja) 局所使用のためのビタミンｋ類似体製剤
MX2013008384A (es) Composiciones topicas de minociclina y metodos de uso de la misma.
TW200820992A (en) Nanoparticulate formulations of modafinil
US20260000660A1 (en) Sustained release local anesthetic hydrogel composition
JP2021529811A (ja) 局所用デトミジン製剤
CA2975163A1 (fr) Formulations pour traiter l'hyperthyroidie
CA3012660C (fr) Compositions d'agents alpha-adrenergique pour le traitement du ptosis
HK40079495A (en) Compositions and uses of alpha-adrenergic agents
JP2024507266A (ja) ヒドロゲル組成物、ならびに放射線によって引き起こされる皮膚損傷の予防および／または処置におけるその使用
Mehak et al. EMULGELS: RECENT DEVELOPMENTS
Dahal Assessment of the Percutaneous Absorption of ABH PLO Gel Across Porcine Ear Skin